Biocytogen Announces Dr. Zhaoxue (Luke) Yu as Global Head of Preclinical Pharmacology
On March 31st, Biocytogen announced Dr. Zhaoxue (Luke) Yu as our Global Head of Preclinical Pharmacology. As our global preclinical pharmacology team leader, Dr. Yu…
Read more
April Webinar: In Vivo vs. In Vitro Therapeutic Antibody Discovery
Date: April 16th, 2020 | 11am EST Presenter: Lei Chen, Ph.D. Senior Director of Antibody Discovery of Biocytogen REGISTER NOW About the webinar in vivo antibody…
Read more
Gene Targeting Service Verified with Industry-leading Quality Control Measures
At Biocytogen, we take pride in our quality control measures when we target and edit genes for our mouse models and drug development endeavors.…
Read more
GEN Magazine Mentions Biocytogen and Its Humanized Mice Model
Showcased in GEN Magazine's March issue, Biocytogen speaks about the current state and imminent future of animal models, specifically on the humanization of mouse models…
Read more
Nature Research Webcast: Accelerating therapeutic antibody discovery with fully human antibody mice
Date: December 10, 2019 Time: 8am PST / 11am EST / 4pm GMT / 5pm CET Register Now Overview: Production of fully human antibody is a…
Read more
The Utility of the Rosa26 Knock-in Mouse
The Rosa26 locus in the mouse genome is a “safe harbor” which allows researchers to express genes of interest. Different gene targeting technologies (embryonic stem…
Read more
RenMab™ Mouse Featured in GEN Magazine
Biocytogen's RenMab™ Mouse is featured in the Nov. Issue of Genetic Engineering & Biotechnology News (GEN). Read the full article here. RenMab™ Mouse highlights: Developed…
Read more
Biocytogen’s RenMab™ Mouse is Featured on Fiercebiotech
Biocytogen's RenMab™ Mouse is featured on Fiercebiotech.com today. Read the full article here. RenMab™ Mouse highlights: Developed upon Biocytogen’s unique Mb-scale chromosome engineering technology Variable…
Read more
2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
Location: Hilton Garden Inn Philadelphia Center City Dates: Sept. 19-20, 2019 Booth: #Ex-7 Presentation Title: Accelerating Therapeutic Antibody Discovery and Development with Innovative Humanized Mouse…
Read more
Biocytogen Closes $79M Series D Funding
On August 2019, Beijing Biocytogen Co., Ltd. ("Biocytogen") announced the closing of its Series D funding of $79M (RMB 543M). This round of financing was…
Read more